Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation

BACKGROUND/AIMS: The safety of direct oral anticoagulants (DOACs) compared with warfarin in patients with both nonvalvular atrial fibrillation (AF) and clinically confirmed liver cirrhosis (LC) has not been well studied. We compared the risk of a major bleeding event between DOAC and warfarin treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Seo Yeon, Kim, Eunju, Nam, Gi-Byoung, Lee, Danbi, Shim, Ju Hyun, Kim, Kang Mo, Lim, Young-Suk, Lee, Han Chu, Chung, Young-Hwa, Lee, Yung Sang, Choi, Jonggi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082430/
https://www.ncbi.nlm.nih.gov/pubmed/35078306
http://dx.doi.org/10.3904/kjim.2020.622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082430/
https://www.ncbi.nlm.nih.gov/pubmed/35078306
http://dx.doi.org/10.3904/kjim.2020.622

Ejemplares similares